Storia in 19 fonti

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in its portfolio beyond Covid-19.

Raccontata da

spiegel.de+7 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo14 h fa

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Moderna shares surged after positive Phase 3 results for its Merck-partnered melanoma cancer vaccine, boosting confidence in its portfolio beyond Covid-19.

originale

Timeline cronologica

mercoledì 19 agosto 2026·biopharmadive.com
Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma
At an interim data check, investigators of a key trial found the individualized mRNA treatment kept disease from returning and stopped its spread, sparking a surge in Moderna…
mercoledì 19 agosto 2026·expansion.com
Moderna se dispara m�s del 140% en Bolsa al anunciar resultados positivos en un ensayo cl�nico
Las acciones de las norteamericanas Moderna y Merck (conocida fuera de Estados Unidos y Canad� como MSD) se dispararon este mi�rcoles durante su negociaci�n en el mercado...

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Confronto fonti

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Timeline cronologica

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

Moderna se dispara m�s del 140% en Bolsa al anunciar resultados positivos en un ensayo cl�nico

Moderna and Merck shares soar on mRNA cancer vaccine

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in…

Moderna and Merck cancer vaccine returns ‘landmark’ result in melanoma

Moderna shares nearly triple on skin cancer vaccine success

Moderna shares double after experimental mRNA cancer treatment passes key test

Moderna vola a Wall Street: titolo a +130% dopo i dati sul melanoma - SoldiOnline.it

'Breakthrough' mRNA cancer drug curbs melanoma in large trial

Merck, Moderna say melanoma vaccine meets goals in large trial | CBC News

Il vaccino mRNA contro il melanoma funziona: Moderna vola in Borsa

Moderna y Merck se disparan en Wall Street tras resultados prometedores de vacuna contra cáncer de piel - EFE

Moderna y Merck se disparan en bolsa tras anunciar resultados prometedores contra el melanoma

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks…

Vaccino sperimentale anti melanoma, Moderna fa +160% in Borsa

Moderna und Merck: Krebsimpfstoff Intismeran besteht Phase 3 – Aktien steigen massiv

Moderna: Erfolgreiche Studie zu Hautkrebs-Impfstoff beflügelt Börsenkurs

For Moderna, cancer vaccine results ease investor skepticism on its future as stock soars

Dow Jones Top Company Headlines at 3 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...

Moderna and Merck shares soar on mRNA cancer vaccine

New Cancer Treatment Hope After mRNA Vaccine Success

Moderna, Merck unveil mRNA-based cancer vaccine that cuts spread

‘Landmark’: New mRNA vaccine could prevent skin cancer from returning, companies say

Ações da Moderna dobram de valor com sucesso de teste de vacina contra melanoma

Dow Jones Top Company Headlines at 5 PM ET: Moderna Shares More Than Double on Success of mRNA Cancer Vaccine | OpenAI's ...